Tennessee Pharmacists Association

Tennessee PBM Reform Resource Hub

TPA has compiled these resources for Tennessee pharmacies to navigate PBM issues, including:  appeals, complaints, and dispensing fees to comply with state PBM reform laws and regulations.

TPA continues to advocate for increased transparency and accountability for Pharmacy Benefits Managers (PBMs) at the state level. These enacted laws ensure that pharmacies have the ability to maintain a level playing field with respect to the practices of PBMs. Ongoing state advocacy efforts include protections for patient access to pharmacist-provided care, pharmacy audit restrictions, increased transparency and accountability for pharmacy payments from PBMs, and other essential PBM reform laws.

It is important to note that any laws enacted in Tennessee or any other state cannot be enforced on federally-funded programs, such as TRICARE or Medicare plans. The information provided below can help guide pharmacies in handling concerns with PBMs managing commercial health plans. For more information on TennCare, please visit here.

 

Overview of Recent PBM Reform in Tennessee

In 2021, Public Chapter 569 was adopted to demonstrate the need for fair reimbursement and ability to serve as any willing provider for commercial insurance plans. In 2022, this was updated as Public Chapter 1070 to requires PBMs to follow clear rules for reimbursements, appeals, and pharmacy choice. The Tennessee Department of Commerce & Insurance (TDCI) enforces these requirements. Additionally, the FAIR Rx Act passed in 2026, which addressed pharmacy ownership by PBMs in Tennessee. 

Pharmacies now have standardized tools to appeal reimbursement decisions, request external reviews, and report PBM violations.

Deadlines at a Glance

  • 7 business days – File an initial appeal with the PBM within 7 business days after a reimbursement decision.
  • 5 business days – After receiving an appeal, the PBM has 5 business days to request additional information if the appeal is incomplete. The pharmacy then has 5 business days to provide the additional information. 
  • 7 business days – PBM must respond to the pharmacy’s complete initial appeal within 7 business days of receipt.
  • 30 calendar days – If denied, you can request an external appeal to TDCI/Myers & Stauffer.
  • 10 business days – PBM may respond to TDCI on external appeal within 10 business days of receipt of notice from the Commissioner.
  • 90 calendar days – Final external appeal decision issued.
  • 7 business days – PBM must pay after a favorable appeal decision.

Step 1: Initial Rate Review Request through the PBM

  • Use the PBMs proper channels to submit a rate review request when a payment is not covering the cost to the pharmacy for a brand or generic medication.
  • PBMs are required to use a standard format for pharmacy reimbursement appeals.
  • Communicate with your PSAO or Corporate Office to verify what part of this process may be handled for you.
  • Submit within 7 business days after submitting the initial claim for reimbursement. Be ready to include supporting documentation (invoice, proof of acquisition cost, claim detail).
  • PBM must respond within 7 business days.
  • Upon a denied request or an approval that still doesn’t cover your full cost associated with medication, proceed to next step.

 

Step 2: External Appeal to TDCI/Myers & Stauffer

  • If denied, request an external appeal within 30 calendar days of the PBM’s decision.
  • File online through the Myers & Stauffer portal.
  • Attach the original appeal, PBM’s response, and supporting documentation.
  • The external reviewer issues a final decision within 90 days.
  • Additional contact information for Myers & Stauffer: email (TNPBMAppeals@mslc.com), help desk (800-591-1183), and fax (317-815-2971).
 

If the external appeal favors the pharmacy, the PBM must make the additional payment within 7 business days after receiving the written decision.

Separate from the appeal process for reimbursement of drug product, pharmacies may also file a complaint with TDCI if a PBM engages in prohibited conduct (e.g., steering patients, failing to follow appeal timelines).

TDCI will work to address complaints pertaining to:

  • Initial Reimbursement appeal process, notice or timely payment: PBM failing to follow requirements for initial appeal process. Tenn. Comp. R. & Regs. 0780-01-95-.04 &.05
  • Dispensing Fee: Insurer or PBM failing to pay the appropriate dispense fee to a low-volume pharmacy. T.C.A. § 56-7-3206
  • Steering: Insurer or PBM interfering with an insured’s right to choose a contracted pharmacy. T.C.A. § 56-7-3120
  • Audits: Insurer or PBM failing to comply with statutory requirements for audits of pharmacy/pharmacist. T.C.A. § 56-7-3103
  • Prompt Pay for clean pharmacy claims: PBM failing to comply with Prompt Payment Standards for clean pharmacy claims T.C.A. § 56-7-3124
  • Step Therapy: Insurer or PBM failing to provide a step therapy exception. T.C.A. § 56-7-3502
  • Allowing Disclosures: Insurer or PBM penalizing a pharmacy for (or restricting pharmacy from) disclosing a lower price available for a prescription drug by not using health insurance for prescription purchase. T.C.A. § 56-7-3114
  • Other: Please describe below if your complaint does not fall into the above categories

As part of 2022 Public Chapter 1070, pharmacies that meet low-volume thresholds per TennCare standards may qualify for the enhanced dispensing fee of $13.16 per prescription (current TennCare rate as of November 1, 2023)

  • Eligibility: Fewer than 65,000 prescriptions annually.
  • The pharmacy is required to certify this eligibility each year by December 1. Certification must be submitted to each PBM individually.
  • Certification covers the July 1 – June 30 look-back period.
  • TDCI confirm eligibility and notify PBMs.

Click here to download a template attestation document that you can fill out and submit to each PBM you work with. TPA has maintained an online directory below to assist pharmacies on where to submit your certification.

ALLUMAnetworkcompliance@express-scripts.com
AMWINS GROUP BENEFITS LLCProvRelContracting@elixirsolutions.com
ARCHIMEDES LLCmemberservices@archimedesrx.com
BENECARD SERVICES INC.NetworkQuality@benecardpbf.com
CAPITAL RX INC.Provider.Relations@cap-rx.com
CAREMARK L.L.C.Qualtrics Survey | Qualtrics Experience Management
CENTENE PHARMACY SERVICES INC.claimsprocessing@centene.com
CHANGE HEALTHCARE PHARMACY SOLUTIONS INC.Provider.Relations@changehealthcare.com
CIGNA HEALTH AND LIFE INSURANCE COMPANYNetworkCompliance@express-scripts.com
CITIZEN’S RX LLCproviderrelations@citizensrx.com
DST PHARMACY SOLUTIONS INC.rservice@dsthealth.com
ELIXIR RX SOLUTIONS LLCProvRelContracting@elixirsolutions.com
EMPLOYEE HEALTH INSURANCE MANAGEMENT INC.rxreimbursements@ehimrx.com
ENVOLVE PHARMACY SOLUTIONSclaimsprocessing@centene.com
EPIPHANY RX LLCpharmacynetwork@epiphanyrx.com
EXPRESS SCRIPTS LLCAttestation Form to NetworkCompliance@express-scripts.com
HEALTHCARE HIGHWAYS RX LLCproviderrelations@hchrx.com
HUMANA PHARMACY SOLUTIONS INC.PharmacyContractRequest@humana.com
INDEPENDENT HEALTH’S PHARMACY BENEFIT DIMENSIONS LLCproviderservice@servicing.independenthealth.com
INTEGRATED PRESCRIPTION MANAGEMENT INCORPORATEDpharmacycontracts@rxipm.com
KROGER PRESCRIPTION PLANS INC.rxplans@kroger.com
MAGELLAN RX MANAGEMENT LLCRxNetworksDept@magellanhealth.com
MAXCAREpharmacynetworks@maxcarerx.com
MAXORPLUS LTD.providerrelations@maxor.com
MEDIMPACT HEALTHCARE SYSTEMS INC.PharmacyOperationsSups@medimpact.com
MEDONEproviderrelations@medone-rx.com
MERIDIANRX LLCpharmacyservices@meridianrx.com
NAVITUS HEALTH SOLUTIONS LLC.providerrelations@navitus.com
OPTUMRX INC.provider.relations@optum.com
PERFORMRX LLCpharmacynetworkcredentials@performrx.com
PHARMACY DATA MANAGEMENT INC.pharmacyenrollment@pdmi.com
PHARMPIXretailnetwork@pharmpix.com
PRESCRYPTIVE HEALTH INC.pharmacyrelations@prescryptive.com
PRIME THERAPEUTICS LLCPharmacyOps@primetherapeutics.com
PROACT INC.updates@proactrx.com
PROCARE PHARMACY BENEFIT MANAGER INC.network@procarerx.com
RXSENSEpharmacynet@rxsense.com
SAV-RXprovider@savrx.com
SCRIPT CARE LTD.providerinfo@scriptcare.com
SMITHRXpharmacynetwork@smithrx.com
SOUTHERN SCRIPTS LLCpharmacynetwork@southernscripts.net
VENTEGRAnetwork@ventegra.com
WELLDYNERX LLCPharmacyInfo@welldyne.com

Q: Do I have to use the Standard Appeal Form?
Yes. PBMs are required to accept the TDCI-issued form.

Q: What documentation counts as “actual cost”?
Invoices, purchase orders, or wholesaler statements are acceptable.

Q: Can appeals apply to similarly situated pharmacies?
Yes. PBMs must correct reimbursements across similarly situated pharmacies.

Q: When should I file a complaint vs. an appeal?

  • File an appeal for reimbursement disputes.
  • File a complaint for systemic or policy violations (e.g., patient steering, network issues).

Q: What do I do if the claim is against a PBM contracted with a federal program?

  • Creation and oversight of the PBM process for state government programs (TCA Title 4)
  • Prompt Pay Requirements (TCA 56-7-126)
  • “Any Willing Pharmacy” Statute (TCA 56-7-2359)
  • Patient Choice Statute (TCA 56-7-3120)
  • Standards for PBM Identification Cards (TCA 56-7-2361)
  • Audit and Recoupment Restrictions for Pharmacy Services (TCA 56-7-2362)
  • Pharmacy Audit Bill of Rights and Restrictions on MAC Lists (TCA 56-7-3101 through TCA 56-7-3112)
  • Licensure as Pharmacy Benefits Manager (Mandatory PBM Licensure) (TCA 56-7-3113)
  • Right to Provide Information Regarding Amount of Insured’s Cost Share of Prescription Drug (Prohibition on PBM Gag Clauses) (TCA 56-7-3114)
  • Prohibition on PBMs from Assessing Retroactive, Non-Transparent Fees on Pharmacists or Pharmacies (TCA 56-7-3115)
  • Prohibition on PBMs from Requiring Pharmacists to Dispense Contrary to Professional Judgment (TCA 56-7-3116)
  • Prompt Payment Standards for PBMs (T.C.A. 56-7-3124)
  • Prohibition on PBMs for Utilizing Spread Pricing and Prohibition Against Below Cost Claims (TCA 56-7-3206)
  • Disclosure of Material Changes to Contract Provisions (TCA 56-7-3117)
  • Additional Contract Protections and Prohibited PBM Practices (TCA 56-7-3118)
  • Discrimination Against 340B Entities (TCA 56-7-3119)
  • Cost Calculations and Pharmacy Right to Disclose Costs to Patients (TCA 56-7-3201 through TCA 56-7-3204)
  • Real Time Benefit Tool (TCA 56-7-3208)
  • Audit and Recoupment Restrictions for Pharmacy Claims (TCA 56-32-138)
  • Freedom, Access, and Integrity in Registered Pharmacy (FAIR Rx) Act (TCA 63-10-316)
  • PBM Authorization Statutes for TennCare (TCA 71-5-138, TCA 71-5-197, TCA 71-5-198)

These laws can also be accessed online in the Tennessee Code Annotated (TCA).

OptumRx is TennCare’s pharmacy benefits administrator (PBA). Prime Therapeutics will be the TennCare PBA with a go-live date of October 1, 2027. Visit the TennCare Pharmacy Benefits Manager page for current provider information and TennCare-specific resources.

 

Rutledge vs. PCMA

On December 10, 2020, the Supreme Court handed a significant win to states and broadened the path forward for state health care cost control efforts. In Rutledge vs. Pharmaceutical Care Management Association (PCMA), the Court ruled 8-0 that the Employee Retirement Income Security Act (ERISA) did not preempt Arkansas’s law regulating pharmacy benefit managers (PBMs), the intermediaries that administer prescription drug benefits for health plans.

This ruling makes a large impact on the state of Tennessee’s ability to regulate PBMs. Some questions did arise from the Rutledge vs. PCMA case around exactly what aspects of these plans are able to be regulated. There have been some interpretations that the decision only applies to “cost regulation” and that other pending court cases will take up other aspects. However, with the passage of Public Chapter 569 in 2021, the Tennessee Department of Commerce and Insurance issued a bulletin that stated all aspects of the Public Chapter would apply to ERISA plans, including patients’ right to choose their pharmacy.

What does ERISA mean?

ERISA is a federal statute that regulates most forms of private employer- and union-sponsored healthcare plans. It includes a preemption clause, which provides that ERISA displaces certain State laws that apply to ERISA-covered plans. The question presented in Rutledge is whether ERISA preempts, or allows these plans to not follow, State laws that regulate PBM-pharmacy reimbursements and the relationship of these entities more generally.